312 related articles for article (PubMed ID: 14639545)
1. Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity.
Welsch JA; Moe GR; Rossi R; Adu-Bobie J; Rappuoli R; Granoff DM
J Infect Dis; 2003 Dec; 188(11):1730-40. PubMed ID: 14639545
[TBL] [Abstract][Full Text] [Related]
2. Assessment of vaccine potential of the Neisseria-specific protein NMB0938.
Sardiñas G; Climent Y; Rodríguez Y; González S; García D; Cobas K; Caballero E; Pérez Y; Brookes C; Taylor S; Gorringe A; Delgado M; Pajón R; Yero D
Vaccine; 2009 Nov; 27(49):6910-7. PubMed ID: 19751688
[TBL] [Abstract][Full Text] [Related]
3. Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine.
Welsch JA; Rossi R; Comanducci M; Granoff DM
J Immunol; 2004 May; 172(9):5606-15. PubMed ID: 15100304
[TBL] [Abstract][Full Text] [Related]
4. Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870.
Hou VC; Koeberling O; Welsch JA; Granoff DM
J Infect Dis; 2005 Aug; 192(4):580-90. PubMed ID: 16028126
[TBL] [Abstract][Full Text] [Related]
5. Functional activity of anti-Neisserial surface protein A monoclonal antibodies against strains of Neisseria meningitidis serogroup B.
Moe GR; Zuno-Mitchell P; Lee SS; Lucas AH; Granoff DM
Infect Immun; 2001 Jun; 69(6):3762-71. PubMed ID: 11349041
[TBL] [Abstract][Full Text] [Related]
6. Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens.
Jacobsson S; Thulin S; Mölling P; Unemo M; Comanducci M; Rappuoli R; Olcén P
Vaccine; 2006 Mar; 24(12):2161-8. PubMed ID: 16321460
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate.
Delgado M; Yero D; Niebla O; González S; Climent Y; Pérez Y; Cobas K; Caballero E; García D; Pajón R
Vaccine; 2007 Dec; 25(50):8420-31. PubMed ID: 17996338
[TBL] [Abstract][Full Text] [Related]
8. Influence of sequence variability on bactericidal activity sera induced by Factor H binding protein variant 1.1.
Brunelli B; Del Tordello E; Palumbo E; Biolchi A; Bambini S; Comanducci M; Muzzi A; Pizza M; Rappuoli R; Donnelly JJ; Giuliani MM; Serruto D
Vaccine; 2011 Jan; 29(5):1072-81. PubMed ID: 21130753
[TBL] [Abstract][Full Text] [Related]
9. Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus.
Giuliani MM; Biolchi A; Serruto D; Ferlicca F; Vienken K; Oster P; Rappuoli R; Pizza M; Donnelly J
Vaccine; 2010 Jul; 28(31):5023-30. PubMed ID: 20493284
[TBL] [Abstract][Full Text] [Related]
10. Identification of new meningococcal serogroup B surface antigens through a systematic analysis of neisserial genomes.
Pajon R; Yero D; Niebla O; Climent Y; Sardiñas G; García D; Perera Y; Llanes A; Delgado M; Cobas K; Caballero E; Taylor S; Brookes C; Gorringe A
Vaccine; 2009 Dec; 28(2):532-41. PubMed ID: 19837092
[TBL] [Abstract][Full Text] [Related]
11. Highly conserved Neisseria meningitidis inner-core lipopolysaccharide epitope confers protection against experimental meningococcal bacteremia.
Plested JS; Harris SL; Wright JC; Coull PA; Makepeace K; Gidney MA; Brisson JR; Richards JC; Granoff DM; Moxon ER
J Infect Dis; 2003 Apr; 187(8):1223-34. PubMed ID: 12696001
[TBL] [Abstract][Full Text] [Related]
12. Identification by genomic immunization of a pool of DNA vaccine candidates that confer protective immunity in mice against Neisseria meningitidis serogroup B.
Yero D; Pajón R; Pérez Y; Fariñas M; Cobas K; Diaz D; Solis RL; Acosta A; Brookes C; Taylor S; Gorringe A
Vaccine; 2007 Jul; 25(28):5175-88. PubMed ID: 17544180
[TBL] [Abstract][Full Text] [Related]
13. Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease.
Frasch CE; Borrow R; Donnelly J
Vaccine; 2009 Jun; 27 Suppl 2():B112-6. PubMed ID: 19464093
[TBL] [Abstract][Full Text] [Related]
14. Induction of immune responses by purified outer membrane protein complexes from Neisseria meningitidis.
Marzoa J; Sánchez S; Costoya L; Diéguez-Casal E; Freixeiro P; Brookes C; Allen L; Taylor S; Gorringe AR; Ferreirós CM; Criado MT
Vaccine; 2012 Mar; 30(13):2387-95. PubMed ID: 21911024
[TBL] [Abstract][Full Text] [Related]
15. Immunoproteomic identification of the hypothetical protein NMB1468 as a novel lipoprotein ubiquitous in Neisseria meningitidis with vaccine potential.
Hsu CA; Lin WR; Li JC; Liu YL; Tseng YT; Chang CM; Lee YS; Yang CY
Proteomics; 2008 May; 8(10):2115-25. PubMed ID: 18491322
[TBL] [Abstract][Full Text] [Related]
16. Sequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strains.
Moe GR; Zuno-Mitchell P; Hammond SN; Granoff DM
Infect Immun; 2002 Nov; 70(11):6021-31. PubMed ID: 12379678
[TBL] [Abstract][Full Text] [Related]
17. Vaccine potential of the Neisseria meningitidis lactoferrin-binding proteins LbpA and LbpB.
Pettersson A; Kortekaas J; Weynants VE; Voet P; Poolman JT; Bos MP; Tommassen J
Vaccine; 2006 Apr; 24(17):3545-57. PubMed ID: 16517031
[TBL] [Abstract][Full Text] [Related]
18. Outer membrane vesicles (OMVs) and detoxified lipooligosaccharide (dLOS) obtained from Brazilian prevalent N. meningitidis serogroup B strains protect mice against homologous and heterologous meningococcal infection and septic shock.
Jessouroun E; da Silveira IF; Larangeira AP; Pereira S; Fernandes SA; Rabinovitch L; Frasch CE; Castro-Faria-Neto HC; Bozza PT
Vaccine; 2004 Jun; 22(20):2617-25. PubMed ID: 15193387
[TBL] [Abstract][Full Text] [Related]
19. A glycoconjugate vaccine for Neisseria meningitidis induces antibodies in human infants that afford protection against meningococcal bacteremia in a neonate rat challenge model.
Mountzouros KT; Belanger KA; Howell AP; Bixler GS; Madore DV
Infect Immun; 2002 Dec; 70(12):6576-82. PubMed ID: 12438327
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of meningococcal PBP2 during natural infection and protective activity of anti-PBP2 antibodies against meningococcal bacteraemia in mice.
Zarantonelli ML; Antignac A; Lancellotti M; Guiyoule A; Alonso JM; Taha MK
J Antimicrob Chemother; 2006 May; 57(5):924-30. PubMed ID: 16513914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
